Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$614K Sell
7,253
-4,932
-40% -$398K 0.05% 322
2026
Q1
$862K Sell
12,185
-3,341
-22% -$250K 0.08% 215
2025
Q4
$1.23M Buy
15,526
+176
+1% +$13.9K 0.12% 153
2025
Q3
$1.26M Sell
15,350
-338
-2% -$26.6K 0.13% 152
2025
Q2
$1.26M Sell
15,688
-1,875
-11% -$145K 0.14% 152
2025
Q1
$1.41M Buy
17,563
+1,527
+10% +$127K 0.16% 121
2024
Q4
$1.31M Buy
16,036
+1,530
+11% +$127K 0.15% 142
2024
Q3
$1.2M Buy
14,506
+7,523
+108% +$562K 0.14% 159
2024
Q2
$490K Sell
6,983
-1,132
-14% -$80.8K 0.1% 222
2024
Q1
$601K Buy
8,115
+4,906
+153% +$342K 0.12% 187
2023
Q4
$212K Sell
3,209
-4,471
-58% -$280K 0.04% 248
2023
Q3
$483K Buy
+7,680
New +$478K 0.16% 131

Other funds holding MET

Norden Group's MET Position: Q2 2026 in Review

Norden Group reduced its MetLife (MET) stake by 40% in Q2 2026, selling an estimated $398K and leaving 7,253 shares worth $614K. The position accounts for 0.05% of the portfolio, ranked #322.

Norden Group first reported a position in MET in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.41M in Q1 2025. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Norden Group held 7,253 shares of MetLife worth $614K as of Q2 2026.
  • Norden Group sold 4,932 MetLife shares in Q2 2026, an estimated $398K.
  • MetLife made up 0.05% of Norden Group's portfolio in Q2 2026, its #322 holding.
  • Norden Group first reported a position in MetLife in Q3 2023 and has held it in 12 quarters since.
  • Norden Group's MetLife position peaked at $1.41M in Q1 2025.
  • 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.